98%
921
2 minutes
20
Objectives: This study is aimed at determining the role of T cells by assessing the numbers of IFN-- and IL-2-secreting T cells following stimulation with peptides derived from DNA topoisomerase-I protein in Thai SSc patients.
Methods: Fifty Thai SSc patients and 50 healthy controls (HC) joined this study. IFN- and IL-2 levels upon stimulation of T cells with 6 peptides derived from DNA topoisomerase-I protein were determined. Anti-nuclear antibodies (ANA) and anti-Scl-70 antibodies were determined by using the ELISA method.
Results: In SSc patients, we detected a significantly higher number of IFN-- and IL-2-secreting CD8 T cells than IFN-- and IL-2-secreting CD4 T cells after stimulation with pooled peptides derived from DNA topoisomerase-I protein. A similar percentage of CD4IL-2, CD4IFN- , and CD8IL-2 were detected following stimulation with DNA topoisomerase-I protein -in SSc patients with anti-Scl-70 antibody (SSc/anti-Scl-70) and those without. In contrast, the amount of CD8IFN- cells was significantly higher in SSc/anti-Scl-70 than those without. Stimulation with individual peptides showed that CSLRVEHINLHPELD (sPep3; 15 amino acids; position 505-519 of DNA topoisomerase-I protein) was the optimal epitope that induced T cells secreting the highest levels of IFN- and IL-2. A higher percentage of IFN- CD4 T cells was detected in SSc/anti-Scl-70 than those without the following stimulation with peptides 2 (amino acid position 475-486 [RAVALYFIDKLA] of protein DNA topoisomerase).
Conclusion: The results from this study emphasize the critical role of DNA topoisomerase-I peptides on the activation of T cells in SSc patients. The findings provide a better understanding of SSc's immunopathogenesis and may lead to the development of diagnostic tools and specific treatments for SSc in the future.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924789 | PMC |
http://dx.doi.org/10.1155/2022/5072154 | DOI Listing |
J Inorg Biochem
December 2025
International Iberian Nanotechnology Laboratory, Avenida Mestre José Veiga s/n, 4715-330 Braga, Portugal.
Topoisomerases are essential hydrolases that facilitate the topological rearrangement of DNA by cleaving nucleic acid strands. Specifically, topoisomerase I (TOPO I) enhances DNA transcription by introducing single-strand breaks in the DNA double helix, relaxing supercoiled DNA, and catalyzing the subsequent re-ligation of the cleavage sites. However, the intricate catalytic mechanism of TOPO I has posed significant challenges for developing effective enzymatic mimics.
View Article and Find Full Text PDFJ Mol Biol
August 2025
Division of Oncology Research, Department of Oncology and Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905. Electronic address:
As an enzyme that relaxes torsionally strained DNA, TOP1 is present in all nucleated human somatic cells. Even though this ubiquity makes TOP1 an unlikely anticancer drug target, six FDA-approved antineoplastic treatments-including two approved in the past five years- and a variety of experimental agents inhibit the TOP1 catalytic cycle. To provide insight into the continuing effort to develop TOP1-directed agents, here we briefly review the biology of TOP1, the cellular effects of stabilizing TOP1-DNA covalent complexes, mechanisms of resistance to TOP1 poisons, and strategies to overcome this resistance before describing efforts to develop TOP1 catalytic inhibitors as well as an exciting new generation of tumor targeting nanoparticles and antibody-drug conjugates that deliver TOP1-directed agents to cancers at high concentrations while sparing normal tissues.
View Article and Find Full Text PDFNat Commun
August 2025
Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
DNA transactions introduce torsional constraints that pose an inherent risk to genome integrity. While topoisomerase 1 (TOP1) activity is essential for DNA supercoil removal, the aberrant stabilization of TOP1:DNA cleavage complexes (TOP1ccs) can result in cytotoxic DNA lesions. What protects genomic hot spots of topological stress from excessive TOP1cc accumulation remains unknown.
View Article and Find Full Text PDFJ Bacteriol
August 2025
Department of Chemistry and Biochemistry, Florida International University, Miami, Florida, USA.
has a DNA topoisomerase I with a unique C-terminal domain (CTD) homologous to eukaryotic SWIB domains. This study focused on determining the function of the SWIB domain-containing TopA from (CtTopA). We demonstrated that, despite the lack of sequence similarity at the CTDs between CtTopA and TopA from (EcTopA), full-length CtTopA removed negative DNA supercoils and complemented the growth defect of a mutant of .
View Article and Find Full Text PDFWiley Interdiscip Rev RNA
August 2025
Department of Biological Chemistry and Pharmacology, Center for RNA Biology, The Ohio State University, Columbus, Ohio, USA.
mRNA translation is a highly orchestrated process that requires spatiotemporal control to ensure each protein is synthesized at the correct abundance, time, and location during human development and physiology. Classically, trans-acting RNA-binding proteins (RBPs) recognize cis-elements within mRNAs to provide one layer of gene-specific translational control. The function and properties of RBPs are diverse, with some harboring enzymatic capabilities, and can be multifaceted if present in larger RBP complexes.
View Article and Find Full Text PDF